Joerg Scheidt

Professor

Hof University of Applied Sciences
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Professor Joerg Scheidt is a faculty member at Hof University of Applied Sciences in Germany. His research primarily focuses on migraine and headache disorders, as demonstrated in his recent articles exploring patient data from the DMKG Headache Registry, as well as studies on treatment efficacy and gender-based differences in pain perception. He contributes significantly to understanding the effectiveness of medication and treatment options for both adults and pediatric populations suffering from headaches.

Articles (9)

Year:

2026

Year:

2026

Year:

2026

Background The Migraine Disability Assessment (MIDAS) is widely used. However, there are limited data on how much a reduction in the MIDAS score indicates a change that matters to the patient. Methods Data from the DMKG (i.e. German Migraine and Headache Society) Headache Registry were used to determine the minimal important difference (MID) of the MIDAS, using the Patient Global Impression of Change (PGIC) as anchor and applying average change and receiver operating characteristic curve methods. Results In total, 1218 adult migraine patients (85.6% female, 40.2 ± 12.8 years, baseline MIDAS 44.2 ± 47.4, follow-up MIDAS 36.5 ± 45.3) were included. For patients with baseline MIDAS >20 (MIDAS grade IV, n = 757), different methods using PGIC “somewhat improved” as anchor yielded percent change MIDs of the MIDAS between −29.4% and −33.2%. For baseline MIDAS between 6 and 20 (grades II and III, n = 334), using PGIC “much improved” as anchor, difference change MIDs were between −3.5 and −4.5 points. Conclusions Based on the above results, we estimated the MID of the MIDAS at −30% for patients with a baseline MIDAS >20, and at −4 points for those with a baseline MIDAS of 6–20, for a tertiary headache care population. Trial Registration The DMKG Headache Registry is registered with the German Clinical Trials Register (DRKS 00021081).

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Tim Jürgens

Researcher, Lecturer

Rostock University Medical Center

GERMANY
View details

Gudrun Gossrau

Prof. Dr

University Hospital Carl Gustav Carus

GERMANY
View details

Victoria Ruschil

University of Tübingen

GERMANY
View details

Florian Adamsky

Professor

Hof University of Applied Sciences

GERMANY
View details